These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32421150)

  • 21. Experts Discuss COVID-19-Remdesivir, Vaccines, and More.
    JAMA; 2020 Aug; 324(8):730-731. PubMed ID: 32777002
    [No Abstract]   [Full Text] [Related]  

  • 22. The COVID-19 pandemic.
    Salahuddin N
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S4-S6. PubMed ID: 32515365
    [No Abstract]   [Full Text] [Related]  

  • 23. COVID-19 vaccines for all?
    Usher AD
    Lancet; 2020 Jun; 395(10240):1822-1823. PubMed ID: 32534638
    [No Abstract]   [Full Text] [Related]  

  • 24. Audio Interview: What the U.S. Response to Covid-19 Looks Like Today.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Nov; 383(19):e123. PubMed ID: 33211936
    [No Abstract]   [Full Text] [Related]  

  • 25. Audio Interview: An Update from Operation Warp Speed.
    Rubin EJ; Baden LR; Woodcock J; Morrissey S
    N Engl J Med; 2020 Nov; 383(20):e127. PubMed ID: 33176090
    [No Abstract]   [Full Text] [Related]  

  • 26. COVID-19: Small-Molecule Clinical Trials Landscape.
    Ferreira LLG; Andricopulo AD
    Curr Top Med Chem; 2020; 20(18):1577-1580. PubMed ID: 32862824
    [No Abstract]   [Full Text] [Related]  

  • 27. Global governance for COVID-19 vaccines.
    The Lancet
    Lancet; 2020 Jun; 395(10241):1883. PubMed ID: 32563355
    [No Abstract]   [Full Text] [Related]  

  • 28. Artificial intelligence and machine learning to fight COVID-19.
    Alimadadi A; Aryal S; Manandhar I; Munroe PB; Joe B; Cheng X
    Physiol Genomics; 2020 Apr; 52(4):200-202. PubMed ID: 32216577
    [No Abstract]   [Full Text] [Related]  

  • 29. COVID-19: Some clinical questions after the first 4 months.
    Bassetti M; Ansaldi F; Icardi G; Pelosi P; Robba C; Taramasso L; Trucchi C; Vena A; Giacobbe DR
    Eur J Clin Invest; 2020 Jul; 50(7):e13326. PubMed ID: 32562550
    [No Abstract]   [Full Text] [Related]  

  • 30. Intensifying vaccine production.
    Bull World Health Organ; 2020 May; 98(5):302-303. PubMed ID: 32514194
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19: How has the scientific community risen to the challenge?
    Straiton J
    Biotechniques; 2020 May; 68(5):232-234. PubMed ID: 32319301
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Current development of COVID-19 diagnostics, vaccines and therapeutics.
    Zhang N; Li C; Hu Y; Li K; Liang J; Wang L; Du L; Jiang S
    Microbes Infect; 2020; 22(6-7):231-235. PubMed ID: 32387332
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Why do SARS-COV vaccines not exist? The pharma scientific intelligence and business model must be revisited!
    Boudjelal M; Nehdi A; Islam I
    Expert Opin Drug Discov; 2020 Nov; 15(11):1233-1235. PubMed ID: 32543297
    [No Abstract]   [Full Text] [Related]  

  • 34. A strategic approach to COVID-19 vaccine R&D.
    Corey L; Mascola JR; Fauci AS; Collins FS
    Science; 2020 May; 368(6494):948-950. PubMed ID: 32393526
    [No Abstract]   [Full Text] [Related]  

  • 35. The race for coronavirus vaccines: a graphical guide.
    Callaway E
    Nature; 2020 Apr; 580(7805):576-577. PubMed ID: 32346146
    [No Abstract]   [Full Text] [Related]  

  • 36. COVID-19 pandemic: what can pharmaceutical formulation and drug delivery experts offer?
    Alany RG
    Pharm Dev Technol; 2020 Jul; 25(6):649. PubMed ID: 32423342
    [No Abstract]   [Full Text] [Related]  

  • 37. Hydroxychloroquine and ivermectin: A synergistic combination for COVID-19 chemoprophylaxis and treatment?
    Patrì A; Fabbrocini G
    J Am Acad Dermatol; 2020 Jun; 82(6):e221. PubMed ID: 32283237
    [No Abstract]   [Full Text] [Related]  

  • 38. Responding to Covid-19 - A Once-in-a-Century Pandemic?
    Gates B
    N Engl J Med; 2020 Apr; 382(18):1677-1679. PubMed ID: 32109012
    [No Abstract]   [Full Text] [Related]  

  • 39. Adverse Consequences of Rushing a SARS-CoV-2 Vaccine: Implications for Public Trust.
    Trogen B; Oshinsky D; Caplan A
    JAMA; 2020 Jun; 323(24):2460-2461. PubMed ID: 32453392
    [No Abstract]   [Full Text] [Related]  

  • 40. Ensuring global access to COVID-19 vaccines.
    Yamey G; Schäferhoff M; Hatchett R; Pate M; Zhao F; McDade KK
    Lancet; 2020 May; 395(10234):1405-1406. PubMed ID: 32243778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.